The prevalence and clinical implications of bronchiectasis in patients with sarcoidosis

A. Haywood (San Antonio, Texas, United States of America), J. Castaneda (San Antonio, Texas, United States of America), K. Proud (San Antonio, Texas, United States of America), M. Restrepo (San Antonio, Texas, United States of America), A. Diaz (Boston, Massachusetts, United States of America), D. Maselli (San Antonio, Texas, United States of America)

Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Session: Sarcoidosis: a multifaceted disease that is difficult to manage
Session type: Thematic Poster
Number: 1394
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Haywood (San Antonio, Texas, United States of America), J. Castaneda (San Antonio, Texas, United States of America), K. Proud (San Antonio, Texas, United States of America), M. Restrepo (San Antonio, Texas, United States of America), A. Diaz (Boston, Massachusetts, United States of America), D. Maselli (San Antonio, Texas, United States of America). The prevalence and clinical implications of bronchiectasis in patients with sarcoidosis. 1394

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Features of tuberculosis incidence and clinical forms for sarcoidosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 202s
Year: 2004

Occurrence and impact of bronchiectasis in patients with COPD
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017


Prevalence and clinical relevance of comorbidities in IPF
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018

The features of patients with sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 436s
Year: 2002

Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020

Effects of exacerbation risk on symptoms and clinical characteristics in patients with bronchiectasis
Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation
Year: 2012

Clinical relevance of bronchiectasis in COPD
Source: Annual Congress 2010 - COPD: diagnosis
Year: 2010


Aetiological testing in patients with bronchiectasis
Source: International Congress 2014 – PG08 The management of non-CF bronchiectasis: from childhood to adulthood
Year: 2014




The prognostic role of the bronchiectasis in patients with COPD
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017

Pulmonary aspergilloma: epidemiology and clinical features of Iranian patients
Source: Eur Respir J 2002; 20: Suppl. 38, 352s
Year: 2002

Prevalence of ocular sarcoidosis in patients with intra thoracic sarcoidosis
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016


Clinical features of COPD in patients with chronic pulmonary aspergillosis
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009


The comparison of sarcoidosis patients with benign and recurrent clinical course of the disease
Source: Eur Respir J 2005; 26: Suppl. 49, 331s
Year: 2005

Relationship between clinical symptoms and severity of alveolitis in patients with new-onset sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 468s
Year: 2002

Impact of comorbidities and etiology of bronchiectasis on outcomes in hospitalised patients with bronchiectasis
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015

Radiological features of NTM pulmonary disease in patients with bronchiectasis
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020


Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013


Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients
Source: Breathe, 16 (1) 190321; 10.1183/20734735.0321-2019
Year: 2020



Ocular manifestations in unselected group of sarcoid patients hospitalised in the national tuberculosis and lung diseases research institute
Source: Eur Respir J 2002; 20: Suppl. 38, 435s
Year: 2002

Relationship between clinical and radiological signs of bronchiectasis in COPD patients: Results from COSYCONET
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020